What are the benefits of Cxbladder?
Cxbladder is a suite of non-invasive genomic urine tests optimized for the risk stratification of urothelial cancer. The tests help you improve the overall patient experience, while prioritizing your time and clinical resources to optimize practice workflow and improve efficiency.
Make the most of your time and clinical resources
The Cxbladder suite helps you prioritize your time and clinical resources on those who need it the most, streamlining practice workflow and increasing overall efficiency
Works for both you and your patients
Spare patients with a low probability of urothelial cancer the discomfort, anxiety and risks of an invasive procedure. With urine-based sampling and the option of in-home sample collection, the Cxbladder suite allows you to optimize your clinical resources and practice workflow while delivering the best patient experience possible.
Optimize your clinical practice
Prioritize your time and clinical resources on those who need care.
Reduce the number of unnecessary cystoscopies to increase diagnostic yield and overall practice efficiency.
Improve time utilization so physicians can focus on high risk patients and procedures that require their expertise.
Empower your team with a non-invasive genomic test that allows them to better prioritize and coordinate clinical resource.
Improve the patient experience
Spare patients with a low probability of UC the discomfort, anxiety and risks of an invasive procedure.
Identify those who would benefit from priority care in-clinic earlier in the patent care pathway. Focus your time and resources on those who need it sooner, reducing patient waiting times.
Reduce the burden of repeat cystoscopy in those with a low risk of recurrence, improving patient comfort, while helping to ensure continued compliance with scheduled surveillance checks.
Reduce the travel requirement on patients, improving access.
Start your Cxbladder journey
Contact our customer service team
Learn more about the Cxbladder suite and how to implement it in your practice.
Featured resources
Platform Reduces Unnecessary Cystoscopies for Hematuria
Dr. Zachary Klaassen interviews Dr. John Sfakianos about implementing the Cxbladder platform for microhematuria risk stratification and bladder cancer surveillance. Dr. Sfakianos discusses how high-quality biomarkers address the longstanding need to avoid over-diagnosing patients with microhematuria, where historically everyone received cystoscopy despite most having no significant findings.
Advancing Microhematuria Evaluation: The Impact of Urinary Biomarkers and Updated Guidelines
Dr. Jay Raman and Dr. Yair Lotan sit down with Dr. Zachary Klaassen to discuss the latest developments in microhematuria evaluation. Topics include the unmet need in risk stratifying patients, the evolution of the AUA Microhematuria Guideline from 2020 to 2025, and the role of urinary biomarkers in optimizing patient care, including Cxbladder Triage, a test now included in the Guideline*.
SESAUA 2025 Symposium: Cxbladder Triage - Risk Stratification for Patients with Microhematuria
Dr. Zachary Klaassen covers the recent inclusion of Cxbladder Triage in an amendment to the AUA Microhematuria Guideline*, and the benefits Cxbladder Triage offered in reducing the burden of unnecessary cystoscopies for those with a lower risk of cancer, resulting in less patient discomfort and morbidity.
Cxbladder is a precision test that delivers exceptional performance and clinically actionable results
Cxbladder is an objective test with high sensitivity and NPV.
The Cxbladder suite is supported by an evidence portfolio that includes over 25 peer reviewed publications in leading medical journals.
Cxbladder Triage is now included in the American Urological Association (AUA) Microhematuria Guideline, the first and only UBTM recommended with supporting Level A Evidence.
The Cxbladder suite of tests have been used by over 5,000 urologists in more than 100,000 patients.
Adopting Cxbladder in your clinic
Implementing Cxbladder
Our team are ready to guide and support you in the deployment and use of Cxbladder. Learn more implementation.
Start your Cxbladder journey
Contact our customer service team to learn more about the Cxbladder suite and how to implement it in your practice.
Cxbladder is available around the world
Cxbladder is available in the United States, and in countries across Asia and South America. Cxbladder is also available in New Zealand, Australia, and Israel.